22NW, LP — 13F Holdings & Portfolio
CIK 1694297 · latest 13F-HR filed 2026-08-14
22NW, LP manages $104.7M in 13F-reported U.S. long-equity assets across 14 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are NSP (19.45%), NKTR (18.75%), SRI (17.25%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 1 new position, exited 3, added to 9, and trimmed 2.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
SEATTLE, WA 98104
$104.7M
Long-equity book
14
Distinct positions
2026-06-30
Filed 2026-08-14
+1 / −3 / ↑9 / ↓2
vs 2026-03-31
| Name | Title / Status | Ownership | Type |
|---|
Top Adds (vs prior quarter)
- INSPERITY INC$7.0M +52.8%
- STONERIDGE INC$6.1M +51.6%
- REGENXBIO INC$1.8M +43.0%
- REZOLUTE INC$1.8M +70.5%
- CORE MOLDING TECHNOLOGIES IN$1.5M +29.4%
Top Trims
- LIFECORE BIOMEDICAL INC-$18.9M -100.0%
- MINERALYS THERAPEUTICS INC-$9.0M -74.5%
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | INSPERITY INC | NSP | 45778Q107 | $20.4M | 19.45% | 493,000 | SH |
| 2 | NEKTAR THERAPEUTICS | NKTR | 640268306 | $19.6M | 18.75% | 281,115 | SH |
| 3 | STONERIDGE INC | SRI | 86183P102 | $18.1M | 17.25% | 2,466,975 | SH |
| 4 | FOX FACTORY HLDG CORP | FOXF | 35138V102 | $11.5M | 10.98% | 678,165 | SH |
| 5 | CORE MOLDING TECHNOLOGIES IN | CMT | 218683100 | $6.5M | 6.17% | 273,521 | SH |
| 6 | REGENXBIO INC | RGNX | 75901B107 | $5.9M | 5.64% | 492,759 | SH |
| 7 | CULP INC | CULP | 230215105 | $5.8M | 5.51% | 1,859,061 | SH |
| 8 | REZOLUTE INC | RZLT | 76200L309 | $4.3M | 4.08% | 820,653 | SH |
| 9 | UNIFI INC | UFI | 904677200 | $4.0M | 3.87% | 852,455 | SH |
| 10 | MINERALYS THERAPEUTICS INC | MLYS | 603170101 | $3.1M | 2.93% | 113,840 | SH |
| 11 | TEAM INC | TISI | 878155308 | $2.9M | 2.81% | 170,187 | SH |
| 12 | ELEDON PHARMACEUTICALS INC | ELDN | 28617K101 | $2.5M | 2.40% | 636,364 | SH |
| 13 | TURTLE BEACH CORP | TBCH | 900450206 | $179.7K | 0.17% | 14,430 | SH |
| 14 | LIFECORE BIOMEDICAL INC | LFCR | 514766104 | $6.2K | 0.01% | 1,254 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-06-30 | 2026-08-14 | $104.7M | 14 | 0001214659-26-010406 |
| 2026-03-31 | 2026-05-15 | $145.9M | 16 | 0001214659-26-006481 |
| 2025-12-31 | 2026-02-13 | $237.6M | 20 | 0001214659-26-001725 |
| 2025-09-30 | 2025-11-14 | $212.3M | 21 | 0001214659-25-016649 |